Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...

Consumers Rank Nearly 200 Taylor Swift Tracks, Revealing the Commercial Truth Behind Her Last 10 Albums and the True Value of ...

having served as head of international and commercial roles at Mirati Therapeutics (acquired by Bristol-Myers Squibb), Agios Pharmaceuticals (oncology business acquired by Servier) and at TESARO ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Sri Lanka’s leading e-commerce platform, Daraz, has officially launched its annual 11.11 shopping festival, known as the ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

GSK will also gain worldwide development and commercial rights from Vesalius to a preclinical small molecule program with an initial focus in Parkinson’s disease. Vesalius is redefining common ...

Constellation Energy has applied to reopen a nuclear power plant on Three Mile Island in the Susquehanna — not the one shut after a coolant failure in 1979, but its long-running neighbor, closed by ...

During his time at GSK, Williams was charged with developing business strategies ... Lucid Diagnostics Inc. ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company ...